| Literature DB >> 27074272 |
Mariana Alievi Mari1, Marcelo Matos Cascudo2, João Carlos Alchieri1.
Abstract
OBJECTIVE: To evaluate the child development and evaluate a possible association with the commitment by biopsychosocial factors of children with and without congenital heart disease.Entities:
Mesh:
Year: 2016 PMID: 27074272 PMCID: PMC5062696 DOI: 10.5935/1678-9741.20160001
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Sample characterization (n = 128).
| G1 (n=29) | G2 (n=43) | G3 (n=56) |
| |
|---|---|---|---|---|
| Female gender | 20 (69) | 17 (39.5) | 29 (51.8) | 0.047 |
| Age | ||||
| 1 to 11 months | 9 (31) | 18 (41.9) | 5 (8.9) | |
| 12 to 23 months | 6 (20.7) | 12 (27.8) | 11 (19.6) | <0.0001 |
| 24 to 47 months | 12 (41.4) | 10 (23.3) | 18 (32.2) | |
| 48 to 72 months | 2 (6.9) | 3 (7) | 22 (39.3) | |
| Mother's age | 26.34 (8.13)[ | 29 (6.88)[ | 29.57 (8)[ | 0.177 |
| Father's age | 28.96 (7.69)[ | 31.73 (7.64)[ | 32.1 (9.82)[ | 0.280 |
| Mother's Education (years) | 9 (6-11)[ | 10 (8-11)[ | 10 (7-11.75)[ | 0.295 |
| Father's Education (years) | 9.5 (5-11)[ | 8 (5-11)[ | 9 (6-11)[ | 0.427 |
| Number of Children | 2 (1-3)[ | 2 (1-3)[ | 2 (1-3)[ | 0.537 |
| Only child | 13 (44.8) | 14 (32.6) | 19 (33.9) | |
| The youngest child | 14 (48.3) | 24 (55.8) | 24 (42.9) | 0.413 |
| R$179.00 | R$200.00 | R$289.88 | 0.042 | |
| (141.42-242.00)[ | (103.71-289.71)[ | (136.25-440.31)[ | ||
| Unplanned pregnancy | 15 (51.7) | 24 (55.6) | 40 (71.4) | 0.126 |
| Prenatal | 28 (96.6) | 43 (100) | 50 (89.3) | 0.024 |
| No Problems during pregnancy | 15 (51.7) | 25 (58.1) | 43 (76.8) | 0.036 |
| No Complications at birth | 18 (62.1) | 32 (74.4) | 49 (87.5) | 0.025 |
| No history of Use of Substance during pregnancy | 24 (82.8) | 41 (95.3) | 47 (83.9) | 0.120 |
mean and standard deviation
median and percentiles
Overview of congenital heart disease (G1 and G2) (n=72).
| G1 % | G2 % |
| |
|---|---|---|---|
| Classification of diseases | |||
| Cyanotic | 44.8 | 41.9 | 0.496 |
| Acyanotic | 55.2 | 58.1 | |
| Heart disease discovery | |||
| 1st month of life | 58.7 | 46.5 | |
| 2 months to 1 year | 31 | 37.2 | 0.169 |
| After 1 year of life | 10.3 | 7 | |
| During gestation | - | 9.3 | |
| Number of admissions | 1 (1-1)[ | 2 (1-3)[ | <0.0001 |
| Information received | |||
| Yes | 62.1 | 83.7 | 0.036 |
| Understands the disease | |||
| Yes | 27.6 | 37.2 | 0.405 |
| Partially | 48.3 | 32.6 | |
| Behavioral change | |||
| Yes | 21.4 | 85.7 | <0.0001 |
| Type of changes | |||
| Positive | 7.1 | 50 | |
| Negative | 14.3 | 35.7 | <0.0001 |
| Limits the child's activities | |||
| Yes | 63 | 61.9 | 0.568 |
median and percentiles
General Result of the Denver II Assessment (n = 128).
| G1 | G2 | G3 |
| |
|---|---|---|---|---|
| Normal | 7 (24.1) | 9 (20.8) | 30 (53.6) | |
| Suspect | 11 (38) | 10 (23.3) | 15 (26.8) | <0.0001 |
| Abnormal | 8 (27.6) | 18 (41.9) | 3 (5.3) | |
| Impossible Test | 3 (10.3) | 6 (14) | 8 (14.3) |
Gender and age related to Denver II (n = 111).
| Normal n (%) | Suspect n (%) | Abnormal n (%) |
| |
|---|---|---|---|---|
| Gender | ||||
| Female | 30 (52.6) | 14 (24.6) | 13 (22.8) | 0.042 |
| Men | 16 (29.6) | 22 (40.7) | 16 (29.6) | |
| Age | ||||
| 1 to 11 months | 10 (31.2) | 8 (25) | 14 (43.8) | |
| 12 to 23 months | 9 (36) | 6 (24) | 10 (40) | 0.001 |
| 24 to 47 months | 13 (46.4) | 10 (35.7) | 5 (17.9) | |
| 48 to 72 months | 14 (53.8) | 12 (46.2) | - | |
|
| |
|---|---|
| CHD | = Congenital heart disease |
| DDST | = Denver Developmental Screening Test |
| G1 | = Group 1 |
| G2 | = Group 2 |
| G3 | = Group 3 |
| SUS | = Brazilian National Health Care System |
Relation between income per capita and income for the Denver II * (n = 111).
| Normal | Suspect | Abnormal | |
|---|---|---|---|
| Median | R$ 287.71 | R$ 216.66 | R$ 181.50 |
| Percentiles | R$171.30/R$ 434,86 | R$ 100.00/R$ 286.37 | R$ 133.92/R$ 242.00 |
| Minimum | R$ 0.00 | R$ 22.40 | R$ 36.00 |
| Maximum | R$ 1000.00 | R$ 907.00 | R$ 500.00 |
P=0.019
|
| |
|---|---|
| MAM | Study design; implementation of projects and/or experiments; Analysis and/or interpretation of data; manuscript writing or critical review of its contents; final approval of the manuscript |
| MMC | Final approval of the manuscript |
| JCA | Manuscript writing or critical review of its contents; final approval of the manuscript |